Parkinson's Disease News
News on Parkinson's Disease continually updated from thousands of sources around the net.
1 hr ago | PhysOrg Weblog
Purdue researcher Riyi Shi is commercializing a technology that could reduce the symptoms and pain of neurological disease and injury, including multiple sclerosis, neuropathic pain and Parkinson's disease through his startup Neuro Vigor LLC. The innovation could reduce symptoms and pain by identifying and reducing the amount of a neurotoxin that is produced in the body after nerve cells are injured. Credit: Purdue University photo/Michel Schweinsberg A Purdue startup is commercializing a technology that could reduce the symptoms and pain of neurological disease and injury, including multiple sclerosis, neuropathic pain and Parkinson's disease.
5 hrs ago | Pharmaceutical Processing
MedGenesis Therapeutix has entered into an agreement with Pfizer, granting Pfizer an exclusive, worldwide option to license its glial cell line-derived neurotrophic factor protein and convection enhanced delivery technology to be used in research for potential treatments for Parkinson's disease. Dr. Erich Mohr, Chief Executive Officer and Chairman of MedGenesis commented, "We believe that delivering drugs, including proteins, precisely to the regions of the brain where they are required will allow the potential for better treatments for a whole range of central nervous system disease, and opens up the opportunity for the potential development of truly disease-modifying treatments of neurological diseases.
9 hrs ago | KTNV-TV Las Vegas
The Richard Steele Boxing Club is usually full of kids, but twice a week the boxers are much older and all of them have Parkinson's disease. "I was thinking about how to help older people because I know a lot of them.
10 hrs ago | Forbes.com
As the CEO of X Tech Ventures, I focus on applying game-changing technologies from multiple, diverse domains to revolutionize healthcare. Previously, I was a Senior Fellow Emeritus and the Corporate Director of Global Healthcare and Life Sciences at Lockheed Martin.
12 hrs ago | The Paramus Post
OhioHealth Delay the Diseasea , introduces a new course designed to educate carepartners of people living with Parkinson's disease. In this seminar, the carepartner will learn Parkinson's-specific fitness routines to help the individual with Parkinson's incorporate daily exercise into their lives at home and additional tips about taking care of themselves.
13 hrs ago | CiteULike
To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. This study investigated the possibility that the previously mixed findings relating tocognitive deficits in Parkinsons disease might be attributable to inhomogeneity within thepatients sampled, with attentional deficits occurring only for those Parkinsons patients who alsohave additional frontal lobe impairment.
16 hrs ago | Hispanic Business
Half-Year 2014 Highlights Application for Authorization of safinamide submitted to Swissmedic by Zambon as the Authorization holderNew results with NW-3509, demonstrating potential of unique mechanism to benefit poor responders to antipsychotics in patients with schizophrenia, presented at the 4th In May, Newron achieved a key milestone by submitting safinamide to the US FDA for the indications "safinamide as add-on therapy to a stable dose of a single dopamine agonist" in early Parkinson's disease patients and "safinamide as add-on therapy to levodopa alone or in combination with other Parkinson's disease treatments" in mid-to late stage Parkinson's disease patients.
Using advanced computer models, neuroscience researchers at the University of Copenhagen have gained new knowledge about the complex processes that cause Parkinson's disease. The findings have recently been published in the prestigious Journal of Neuroscience .
On Friday October 3 from 1:00-2:00pm, adults with neurogenic communication disorders will gather at the Cashmere High School Performing Arts Centre to entertain an expected audience of 300-400 for the Christchurch Communication Festival. This free community concert aims to raise awareness about the challenges faced by adults with communication disorders due to stroke, traumatic brain injury, Parkinson's Disease, Multiple Sclerosis and other neurological conditions.
Calico's plans to tackle aging are finally taking shape. After being in stealth mode for a year, the Google-backed biotechnology company said last week it will license and develop potential drugs for neurodegenerative disorders caused by the aging and death of nerve cells.
Documents filed by lawyers representing the National Football League acknowledge that at least one-fourth of players are likely to wind up suffering from dementia, Alzheimer's disease, Parkinson's disease or other cognitive impairments after their careers are over, various media outlets are reporting. According to Reuters reporter Brendan O'Brien, the filing is a summary of the results of an actuarial study which it had commissioned.
COMEDY star Billy Connolly has said he "could have done more" to help tragic actor Robin Williams, who was found hanged last month. COMEDY star Billy Connolly has said he \"could have done more\" to help tragic actor Robin Williams, who was found hanged last month.
A free event designed to give information and advice about Parkinson's disease will take place in the Park Hotel next week. Anyone who has the degenerative neurological condition or has a family member affected by it and wants to know more about it can attend the event, taking place from 4-7 p.m. on Tuesday.
This scientific commentary refers to 'The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa', by Cilia et al. . Preventing the development of motor complications is one of the principal concerns when treating patients with Parkinson's disease, and 'levodopa-sparing' approaches have been commonly touted as the best method of achieving this.
Correspondence to: Cristina Nombela, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge Biomedical Campus, CB2 0PY, UK E-mail: Parkinson's disease is associated with multiple cognitive impairments and increased risk of dementia, but the extent of these deficits varies widely among patients. The ICICLE-PD study was established to define the characteristics and prevalence of cognitive change soon after diagnosis, in a representative cohort of patients, using a multimodal approach.
To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. The human alpha-Synuclein protein is of significant interest because of its association with Parkinson's disease and related neurodegenerative disorders.
Updated: Tue Sep 16, 2014 09:40 pm
Copyright © 2014 Topix LLC